Category: Latest News

A new year promises to bring a wealth of new insights into the nature and management of multiple sclerosis (MS). The study summaries included in this edition of “What’s New in MS Research” highlight the broad spectrum of inquiry that is driving the progress to develop better treatments against the disease.

The world’s leading experts in multiple sclerosis (MS) gathered in Copenhagen, Denmark in September 2024 to share the results of their latest research into the causes, course, and treatment of the disease. That gathering, the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), showcased encouraging findings from a number of vital studies.

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we are the recipients of a Fall 2024 Digital Health Award! We are proud to have been presented with a Silver Digital Health Award in the Web-based Digital Health category

People with relapsing and progressive forms of MS now can receive Ocrevus® (ocrelizumab) via intravenous infusion or Ocrevus Zunovo™ (ocrelizumab and hyaluronidase-ocsq) by subcutaneous injection.

It wasn’t just the music that had multiple sclerosis (MS) researchers, clinicians, and advocates in an upbeat mood when they gathered in Nashville from May 29th through June 1st for the Consortium of Multiple Sclerosis Centers’ (CMSC) 2024 Annual Meeting. Rather, the positive vibes reflected the many encouraging developments in MS research reported during the CMSC’s multi-day gathering.

The Multiple Sclerosis Association of America (MSAA) is proud to announce that we are the recipients of an APEX Award for Excellence from the 36th Annual APEX Awards, as well as a Merit Award from the 31st Annual National Health Information Awards!

The Multiple Sclerosis Association of America (MSAA) is proud to recognize 15 years of our inspiring and interactive online Art Showcase. Each year, MSAA hosts the Art Showcase, encouraging individuals with multiple sclerosis to create and submit works of art along with their personal stories to be shared with the community.

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we are the recipients of three awards from the 26th annual Digital Health Awards®! Organized by the Health Information Resource Center (HIRC), the Digital Health Awards recognize leading digital health resources developed for consumers and health professionals. Award entries are evaluated by type of content, format, targeted consumer audience, and overall quality.

The astounding breadth of research being conducting into the causes, manifestations, and management of multiple sclerosis (MS) was on full display when thousands of physicians, nurses, laboratory scientists, and others gathered in Denver in April for the annual meeting of the American Academy of Neurology (AAN).

The Multiple Sclerosis Association of America (MSAA) and Novartis Pharmaceuticals Corporation have collaborated to develop the Multiple Sclerosis Implementation Network™ (MSIN™). This is an exciting and unique initiative to create a practice-based research network (PBRN) for medical professionals to best support individuals with MS.  MSIN is a patient-centric initiative, emphasizing the vital role of people living with MS and their involvement in this practice-based research network. MSIN will be guided by two advisory boards – one of which will be comprised of people living with MS and their care partners. The other advisory board will be comprised of healthcare professionals, research scientists, and advocacy partners.